2018 Agenda

Wednesday, April 25, 2018

7:30 - 8:30 AM

Registration & Networking Breakfast

8:30 - 8:40 AM

Welcome Remarks

Mark Foley, Managing Director - RWI Ventures

8:40 - 9:10 AM

Fireside Chat With Johnson & Johnson's Sandi Peterson

Sandi Peterson, Group Worldwide Chair - Johnson & Johnson

Interviewed By:
Josh Makower, MD, General Partner - NEA/Founder & Chairman - ExploraMed

9:10 - 9:50 AM

Getting a Grasp on Consumer & Practice Trends

A. Market Overview

Presented By:
Tom Seery, Founder & CEO - RealSelf

DOWNLOAD PRESENTATION

B. Panel Discussion

Participants:
Clint Carnell, Chairman & CEO - HydraFacial
Megan Driscoll, CEO & Founder - EvolveMKD
Kellie Lao, Director of Consumer Marketing, Allergan Medical - Allergan
Aubrey Rankin, Co-Founder & CEO - HintMD
Tom Seery, Founder & CEO - RealSelf

Moderated By:
Steven Dayan, MD, Medical Director, Principal Investigator & Founder - DeNova Research

9:50 - 10:35 AM

Minimally Invasive Rejuvenation Company Showcase

Aesthetics Biomedical | MaryAnn Guerra, CEO | DOWNLOAD PRESENTATION
Cypris Medical | Dan Holton, CEO | DOWNLOAD PRESENTATION
Cytrellis Biosystems | Karen Cronholm, President & CEO | DOWNLOAD PRESENTATION
Recros Medica | Tom Albright, President & CEO | DOWNLOAD PRESENTATION
Sinclair Pharma | Chris Spooner, CEO | DOWNLOAD PRESENTATION
Zift Medical | Eric Simso, CEO | DOWNLOAD PRESENTATION

10:35 - 11:00 AM

Morning Networking & Refreshment Break

11:00 - 11:30 AM

Fireside Chat With Allergan's Brent Saunders

Brent Saunders, Chairman, President & CEO - Allergan

Interviewed By:
Mark Foley, Managing Director - RWI Ventures

11:30 - 12:40 PM

Clash of the Toxin Titans: Will the Products That Dominate Today Determine Tomorrow's Market Leader?

This two-part discussion between industry and clinical leaders will compare the various aesthetics offerings and debate the benefits or drawbacks of each.

  • What does the latest research say about the future of this market segment?
  • How will the emergence of new products shake out the toxins marketplace?
  • Real world efficacy, duration and market position…who has the advantage?

A. Market Overview

Tim Lugo, Principal - William Blair & Company

DOWNLOAD PRESENTATION

B. Industry Panel Discussion

Participants:

Dan Browne, CEO & President - Revance Therapeutics
Alisa Lask, VP & General Manager, US Aesthetic - Nestlé Skin Health (Galderma)
David Moatazedi, SVP, US Medical Aesthetics - Allergan
Bob Rhatigan, CEO - Merz North America
Murthy Simhambhatla, PhD, President and CEO - Evolus

C. Physician Panel Discussion

Participants:

Louis Bucky, MD, FACS, Medical Doctor - Louis P. Bucky, MD, PC
Mark Pinsky, MD, Medical Doctor - Pinsky Plastic Surgery
Deanne Mraz Robinson, MD, FAAD, Director of Body Sculpting Center - Connecticut Dermatology Group (CDG)/Assistant Clinical Professor - Yale New Haven Hospital
Simeon Wall, Jr., MD, FACS, Co-Founder - SurgiStem Technologies

Moderated By:

W. Grant Stevens, MD, FACS, CEO - Marina Plastic Surgery/Chief Medical Officer & Co-Founder - OrangeTwist Institute/Clinical Professor - USC School of Medicine

12:40 - 1:25 PM

Networking Lunch

Sponsored By: Allergan

1:25 - 2:10 PM

The Latest Developments Within the Skincare Revolution

There’s a sea change happening in the skincare world and everything is about to change. Small, independent companies are creating new products and lines that are disruptive and enticing.

Meanwhile, the fight for dermatology dollars has gone online, with some vendors selling on Amazon, threatening the status quo.

Philippe Schaison, CEO of Soltégo will discuss these issues, and what’s coming over the next 12 to 24 months. Schaison, who previously held the role of president of Allergan US Aesthetic and Dermatology, will moderate the panel and look into the future of the skin care vertical.

A. Market Overview

Presented By:

Philippe Schaison, CEO - Soltégo

 DOWNLOAD PRESENTATION

B. Industry Panel Discussion

Participants:

Laurent Combredet, CEO - SENTÉ
Mary Fisher, Chair & CEO - Colorescience
Diane Goostree, President & CEO - Alastin Skincare
Andre Moura, Managing Director - New Mountain Capital/Chairman - Topix Pharmaceuticals
Marc Toulemonde, Group President, L’Oréal Active Cosmetics Division - L’Oréal USA

Moderated By:

Philippe Schaison, CEO - Soltégo

2:10 - 2:50 PM

Investing in the Future of Health & Beauty

The growth of the aesthetics market cannot be overlooked so how do sophisticated investors choose the right companies to fund in an ever-changing and competitive landscape? This session will provide an overview of private funding trends and exits followed by a panel discussion on where they’ve experienced failures, success and are placing bets on future opportunities.

A. Market Overview

Presented By:

Kevin Longo, Northeast Head of Medical Device & Digital Health - Silicon Valley Bank

DOWNLOAD PRESENTATION

B. Investor Panel

Participants:

Craig Drill, Founder & Portfolio Manager - Craig Drill Capital
Kevin Longo, Northeast Head of Medical Device & Digital Health - Silicon Valley Bank
Amir Nashat, PhD, Partner - Polaris Partners
Camille Samuels, Partner - Venrock
Andrew Schiff, MD, Managing Director - Aisling Capital

Moderated By:

Josh Makower, MD, General Partner - NEA/Founder & Chairman - ExploraMed

2:50 - 3:10 PM

Afternoon Networking & Refreshment Break

3:10 - 4:00 PM

Aesthetics Innovation Company Showcase

Aivita Biomedical | Aleksandra Jovanovic Poole, PhD, Vice President, Research & Development | DOWNLOAD PRESENTATION
HintMD | Aubrey Rankin, Co-Founder & CEO | DOWNLOAD PRESENTATION
Obalon Therapeutics | Kelly Huang, PhD, COO
PatientPop | Travis Schneider, CEO | DOWNLOAD PRESENTATION
R2 Dermatology | Gordie Nye, CEO | DOWNLOAD PRESENTATION
Red Spot Interactive | Jason Tuschman, CEO & Founder | DOWNLOAD PRESENTATION
Soltégo | Philippe Schaison, CEO | DOWNLOAD PRESENTATION

4:00 - 4:35 PM

Factors Fueling Growth in the Aesthetic Capital Equipment Market

New data from the American Society of Plastic Surgeons says that minimally invasive cosmetic procedures are up by almost 200 percent since 2000. To manage the ever-increasing demand, physicians need a full set of solutions to provide a myriad of procedures to their patients.

This session will address the factors and trends behind the burgeoning aesthetics capital equipment market with a panel of industry leaders who have cleared the hurdles and found the formula for success.

A. Market Overview:

Presented By:

Jeffrey Hoffman, Senior Managing Director - Guggenheim Securities

B. Panel Discussion:

Participants:

Geoff Crouse, CEO - Syneron Candela
Brad Hauser, VP, Research & Development, General Manager, CoolSculpting - Allergan
Jeffrey Nugent, Chairman & CEO - Sientra
J. Daniel Plants, Chairman of the Board - Cutera/Founder & Chief Investment Officer - Voce Capital Management
Domenic Serafino, Chairman & CEO - Venus Concept

Moderated By:

Mark Foley, Managing Director - RWI Ventures

4:35 - 4:55 PM

Keynote Presentation

Women’s health has become more than just Pap tests and mammograms. Hologic’s CEO will discuss why one of the largest global women’s health companies is making a big push into the aesthetics market with technologies for body contouring, skin revitalization and hair removal in addition to restoring women’s vaginal health.

Stephen MacMillan, Chairman, President & CEO - Hologic

DOWNLOAD PRESENTATION

4:55 - 5:25 PM

Capitalizing on the Crossover Between Women’s Health & Aesthetics Technologies

Women’s health has the potential to be the next big thing in aesthetics. This panel of clinical and industry leaders will discuss new and exciting non-surgical innovations to address unmet clinical needs in areas such as urinary incontinence, menopausal symptoms and vaginal rejuvenation.

Panel Discussion

Participants:

Lori Fontaine, VP, Global Clinical Affairs - Hologic
Leah Millheiser, MD, Clinical Assistant Professor, OB/GYN & Director, Female Sexual Medicine Program - Stanford University School of Medicine
Vladimir Paul-Blanc, President & General Manager - Thermi
Patricia Scheller, CEO - Viveve

Moderated By:

W. Grant Stevens, MD, FACS, CEO - Marina Plastic Surgery/Chief Medical Officer & Co-Founder - OrangeTwist Institute/ Clinical Professor - USC School of Medicine

5:25 - 5:30 PM

Closing Remarks

W. Grant Stevens, MD, FACS, CEO - Marina Plastic Surgery/Chief Medical Officer & Co-Founder - OrangeTwist Institute/Clinical Professor - USC School of Medicine

5:30 - 6:30 PM

Networking Reception